Main Article Content
Abstract
The discovery that most body cells and tissues have vitamin D receptors and that some of them have the enzymatic machinery to convert the circulating form of vitamin D (25-hydroxyvitamin D) into the active form (1,25- dihydroxyvitamin D/1,25(OH)2D3 ) gave a new insight about the function of this vitamin. In the course of time, more and more evidences showed that a low vitamin D level leads to the occurrence or recurrence
of cardiovascular diseases, type II diabetes mellitus (DM), cell dedifferentiation (oncogenesis), and immune derangement (autoimmune diseases such as lupus, type
I DM, rheumatoid arthritis, and multiple sclerosis). Most researchers have agreed that a minimum 25(OH)D3 serum level of about 30 ng/ml or more is necessary for favorable calcium absorption and good health. Until proven otherwise, the balance of the research clearly indicates that oral supplementation in the range of 1,000 IU/day for infants, 2,000 IU/day for children, and 4,000 IU/day for adults is safe and reasonable to meet
physiologic requirements, to promote optimal health, and to reduce the risk of several serious diseases.
of cardiovascular diseases, type II diabetes mellitus (DM), cell dedifferentiation (oncogenesis), and immune derangement (autoimmune diseases such as lupus, type
I DM, rheumatoid arthritis, and multiple sclerosis). Most researchers have agreed that a minimum 25(OH)D3 serum level of about 30 ng/ml or more is necessary for favorable calcium absorption and good health. Until proven otherwise, the balance of the research clearly indicates that oral supplementation in the range of 1,000 IU/day for infants, 2,000 IU/day for children, and 4,000 IU/day for adults is safe and reasonable to meet
physiologic requirements, to promote optimal health, and to reduce the risk of several serious diseases.
Article Details
How to Cite
Albar, Z. (2018). Vitamin D and inflammation. Indonesian Journal of Rheumatology, 1(2). https://doi.org/10.37275/ijr.v2i1.20
References
- Holick MF. Vitamin D defi ciency. N Engl J Med 2007;357:266-81.
- Dairy Council of California. An old vitamin with new health implications.
- Peterson CA, Heffernan ME. Serum tumor necrosis factor-alpha
- concentrations are negatively correlated with serum 25(OH)D
- concentrations in healthy women. J Infl amm 2008;5:10.
- Heaney RP. Vitamin D endocrine physiology. J Bone Miner Res
- ;22 Suppl 2:v25-v27.
- Dobnig H, Pilz S, Scharnagl H et al. Independent association
- of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D
- levels with all-cause and cardiovascular mortality. Arch Intern Med.
- ;168(12):1340-9.
- Cannell JC. Vitamin D lowers infl ammation [Online]. 2008 [cited 2009
- June 16]; Available from: URL:http://www.laganafi tness.com/ezines/
- health-and-fi tness/wellness/vitamin-d-lowers-infl ammation.htm
- Vaszuez A, Manso G, Cannell J. The clinical importance of vitamin D
- (Cholecalciferol): A paradigm shift with implications for all healthcare
- providers. Alternative Therapies. Sept/Oct 2004;10(5):28-37.
- Mora JR, Iwata M, Von Andrian UH. Vitamin effects of the immune
- system: Vitamin A and D take centre stage. Nature Reviews Sept
- ;8:685-98.
- Cantorna MT. Vitamin D and autoimmunity: Is vitamin D status an
- environmental factor affecting autoimmune disease prevalence?
- Proceedings of the Society for Experimental Biology and Medicine
- ;223:230-3.
- Heaney RP. Long-latency defi ciency disease: insights from calcium
- and vitamin D. Am J Clin Nutr 2003;78: 912-9.
- Ayers A. Vitamin D [Online]. 2008 Oct 17 [cited 2009 June 16]; Available
- from: URL:http://coolinginfl ammation.blogspot.com/2008/10/vitamind.
- html
- Fujita T. Calcium paradox: Consequences of calcium defi ciency
- manifested by a wide variety of diseases. Journal of Bone and Mineral
- Metab 2000;18(4):234-6.
- Zehnder D, Bland R, Williams MC et al. Extrarenal expression of 25-
- hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab.
- ;86(2):888-94.
- Christiansen C, Rodbro P, Sjo O. “Anticonvulsant action†of vitamin D in
- epileptic patients ? A controlled pilot study. Br M J 1974;913(2):258-9.
- Goswami R, Mishra SK, Kochupillai N. Prevalence & potential
- signifi cance of vitamin D defi ciency in Asian Indians. Indian J Med
- Res. March 2008;127:229-38.
- Munger KL, Levin LI, Hollis BW et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006;296(23):2832-8.
- Leavitt SB. Vitamin D – A neglected ‘analgesic’ for chronic musculoskeletal pain. [Online]. 2008 June [cited 2009 June 16]; Available from: URL:http://pain-topics.org/pdf/vitamind-report.pdf
- Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud S, et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992;327:1637-42.
- Diamond T, Mason RS. Understanding the importance of vitamin D for bone and systemic health. Medicine Today 2009;10(1):18-25,
- McAlindon TE. Infl uence of vitamin D status on the incidence of progression of knee osteoarthritis. Ann Intern Med 1996;125:353-61.
- Arnold EL, Arnold WJ. Complementary and alternative therapies. In: Klippel JH, Stone JH, Crofford LJ, editors. Primer on the rheumatic diseases. 13th ed. Atlanta, GA: Arthritis Foundation; 2008. p. 664-8.
- Bhalla AK, Amento EP, Clemens TL, Holick MF, Krane SM. Specifi c high-affi nity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab 1983;57:1308-10.
- Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC. 1,25- dihydroxyvitamin D3 receptors in human leukocytes. Science 1983;221:1181-3,.
- van Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 2005;97(1-2):93-101.
- Dietrich T, Nunn M, Dawson-Hughes B, Bischoff-Ferrari HA. Association between serum concentrations of 25-hydroxyvitamin D and gingival infl ammation. Am J Clin Nutr 2005;82:575-80.
- Sun X, Zemel MB. Calcitriol and calcium regulate cytokine production and adipocyte–macrophage cross-talk. J Nutr Biochem. 2008;19:392-9.
- Rothenberg R. Vitamin D defi ciency: the forgotten hormone. [Online].2008 Oct [cited 2009 June 16]; Available from: URL: http://www.ehealthspan.com/download/VitaminD2008.pdf
- Smith GR, Collinson PO, Kiely PD. Diagnosing hypovitaminosis D: serum measurements of calcium, phosphate, and alkaline phosphatase are unreliable, even in the presence of secondary hyperparathyroidism. Rheumatol 2005;32(4):684-9.
- Johnson LE. Vitamin D. Merck Manual. [Online]. 2007 Apr [cited 2010 Feb 19]; Available from: URL:http://www.merck.com/mmpe/sec01/ch004ch004k.html?qt=vitamin%20D&alt=sh#tb004_6
- Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol Am J Clin Nutr 2003;77:204-10.
- Koutkia P, Chen TC, Holick MF. Vitamin D intoxication associated with an over the counter supplement. N Engl J Med 2001;345:66-7.